Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Exploring the Limits of Robotic Surgery for Wilms Tumor: A Descriptive Analysis.

Created on 08 Nov 2026

Authors

Mathilde Glenisson, Giammarco LaBarbera, Aurore Pire, Cécile Lozach, Lory Hage, Julien Grosman, Daniel Orbach, Véronique Minard, Sabine Sarnacki, Nicolas Vinit, Thomas Blanc

Published in

European urology oncology. Nov 07, 2026. Epub Nov 07, 2026.

Abstract

Although open radical nephrectomy (ORN) remains the gold standard for the surgical treatment of Wilms tumor (WT), minimally invasive techniques may be used safely for selected cases. Their current development requires regular updates of surgical guidelines. We previously proposed preliminary criteria guiding robot-assisted radical nephrectomy (RARN) for WT, and, in light of our continued extensive experience, this study aimed to describe the selection of children for RARN, including a new volumetric ratio. All consecutive children who underwent ORN or RARN (2016-2023) for presumptive WT at our center were prospectively included. A volumetric ratio (preoperative tridimensional volumetry of [tumor + healthy kidney] over estimated patient's blood volume) was used to assess tumor volume. Surgical and oncological outcomes were compared between groups. Sixty radical nephrectomies were performed, including 23 RARNs (38%). No statistical difference was observed in oncological outcomes between the groups. RARN procedures in patients with a volumetric ratio <35% were performed without conversions, except for three cases with renal vein thrombus, midline crossing, and minor bleeding. Three children with a volumetric ratio <35% underwent ORN instead of RARN because of organizational issues. Approximately 40% of children in our highly selected cohort were eligible for RARN. In our experience, RARN was feasible for tumors with a volumetric ratio of <35% in the absence of renal vein thrombus, midline crossing, or adjacent-organ infiltration, with the need for external validation.

PMID:
42998924
Bibliographic data and abstract were imported from PubMed on 08 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 14
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement